Elizabeth Liddy McCall

Ms McCall is co-founder of 3 biotechnology companies achieving 3 FDA drug registrations and 1 FDA/CE Mark medical device approval. She is an inventor on patents granted in major jurisdictions translating novel G-protein coupled pharmacology into a therapeutic drug treatment currently in Phase 3 clinical trials. Liddy cofounded IIF venture capital fund, Yuuwa Capital LP. Liddy has over 25 years of experience in senior Board and management roles including Agworld Pty Ltd (acquired), iCeutica Inc group (acquired). Liddy was an Associate Director in the Corporate Advisory Group of Macquarie Bank and prior to that worked as a lawyer with Australian law firm. Liddy has board experience in industries including biotechnology, agritech, funds management/finance, data/software-as-a-service (SAAS) and fast moving consumer goods (FMCG). She is Member of Risk Committee.